🫀 Meta-analyses 2020–2025: does Omega-3 really reduce the risk of heart attacks and strokes
What the largest trials say and why the conclusions are contradictory
The question "do omega-3s help the heart" is one of the most controversial in modern cardiology. On one hand, decades of research linked EPA and DHA to heart health. On the other, large trials of recent years have produced mixed results. It is important to sort this out because omega-3 is one of the best-selling supplements in the world.
Below is an analysis of what key studies (GISSI-Prevenzione, REDUCE-IT, STRENGTH, VITAL) and meta-analyses of 2020–2025 actually showed. Spoiler: the answer depends on the dose, the form (EPA vs DHA) and on which population is being discussed.
Background: from the Eskimos to today
Interest in omega-3 and the heart began in the 1970s, when Danish scientists Bang and Dyerberg noticed that Greenland Inuit, who ate fatty fish, very rarely suffered from cardiovascular disease. This gave rise to the "Eskimo hypothesis" — the idea that fish oil protects the heart.
1970s — the Eskimo hypothesis
Observations by Bang and Dyerberg of the Inuit launched the study of omega-3 in cardiology.
1989 — DART
The DART study showed reduced mortality in men after a heart attack who received fatty fish. The results encouraged cardiologists.
1999 — GISSI-Prevenzione
A large Italian study (~11,000 people) showed reduced mortality after a heart attack when taking omega-3. This cemented supplements in cardiology.
2010s — doubts
Later trials (for example, ORIGIN) did not confirm benefit in people with diabetes or established heart disease. Debate began.
2019–2020 — REDUCE-IT and STRENGTH
Two largest trials gave opposite results: REDUCE-IT (high doses of EPA) — benefit, STRENGTH (EPA+DHA) — no benefit. This began the "golden age" of meta-analyses.
Key randomized trials
To understand meta-analyses, you need to know the main RCTs. Here is their summary:
| Study | Year | Participants | Dose/form | Result |
|---|---|---|---|---|
| GISSI-Prevenzione | 1999 | ~11,000 after heart attack | ~1 g/day EPA+DHA | Reduced mortality |
| DART | 1989 | ~2000 after heart attack | Fatty fish | Reduced mortality |
| ORIGIN | 2012 | ~12,000 with diabetes/high risk | ~1 g/day | No benefit |
| VITAL | 2018 | ~25,000 healthy | 1 g/day | No reduction in heart attacks/strokes |
| REDUCE-IT | 2019 | ~8,000 high risk | 4 g/day pure EPA (icosapent ethyl) | 25% reduction in event risk |
| STRENGTH | 2020 | ~13,000 high risk | 4 g/day EPA+DHA (carboxylate) | No benefit |
Meta-analyses 2020–2025: what they showed
Recent meta-analyses combined data from REDUCE-IT, STRENGTH, VITAL and many other trials. Their conclusions are important for practice.
| Meta-analysis | Year | Main result |
|---|---|---|
| Pooled analysis of high-dose EPA RCTs | 2021 | Reduced risk of heart attacks and cardiovascular events on 4 g of EPA |
| Comprehensive meta-analysis of all omega-3 RCTs | 2022 | No significant benefit at low/moderate doses in the general population |
| Analysis by form (EPA vs DHA) | 2023–2024 | Trend in favor of pure EPA; DHA-predominant mixtures are weaker |
| Analysis by dose | 2024–2025 | Benefit appears at doses ≥ 2–4 g/day in people with high triglycerides |
Omega-3 benefits for the heart in practice
Despite the controversy over heart attacks, omega-3s have confirmed cardiological effects:
Reliable reduction
Omega-3s lower triglycerides by 20–30% — this is the most proven effect. That is why high doses of EPA are prescribed for hypertriglyceridemia.
Elasticity and endothelium
They support vascular endothelial function, contribute to a moderate reduction in blood pressure and improve the elasticity of the vessel wall.
Anti-inflammatory effect
They participate in the synthesis of resolvins and lower markers of systemic inflammation linked to atherosclerosis.
Anti-arrhythmic potential
Some data indicate a stabilizing effect on heart rhythm, although the effect is not universal.
Dosages and forms: why it matters
Study results depend heavily on the dose and form. Here is how this affects the conclusions:
| Scenario | EPA+DHA dose | Who it suits |
|---|---|---|
| General prevention | 250–1000 mg/day | Healthy people who eat little fish |
| Triglyceride support | 1000–2000 mg/day | Moderately elevated triglycerides |
| Therapeutic dose (by prescription) | 2000–4000 mg/day pure EPA | High triglycerides and high risk |
How to correctly read study findings
To avoid getting confused by contradictory headlines, keep a few things in mind:
Look at the dose
Studies with 250 mg and with 4 g give different results. Higher doses show more benefit for the heart.
Distinguish EPA and DHA
Most cardiological effects are associated with EPA. DHA is more important for the brain and eyes. The ratio matters.
Consider the population
Prevention in healthy people (VITAL) and treatment in patients with high triglycerides (REDUCE-IT) are different tasks with different answers.
Look at meta-analyses as a whole
One fragment of a study is not an indicator. Meta-analyses combining dozens of trials give a more reliable picture.
Do omega-3s reduce the risk of a heart attack?
In high doses (4 g EPA/day) in people with high triglycerides — yes, they do (REDUCE-IT, -25%). In ordinary low doses in healthy people, no significant reduction has been proven (VITAL, STRENGTH).
Do omega-3s help with strokes?
The evidence base is weaker than for heart attacks. Some data indicate moderate benefit, but overall the effect on strokes is less pronounced and depends on dose and population.
Why did REDUCE-IT and STRENGTH give different results?
REDUCE-IT used 4 g of pure EPA, STRENGTH used 4 g of EPA+DHA. Differences in form, ratio and placebo properties were the reasons for different results.
What dose of omega-3 is needed for the heart?
For prevention 250–1000 mg of EPA+DHA/day. For lowering triglycerides — up to 2000–4000 mg/day of pure EPA, but this is a therapeutic dose prescribed by a doctor.
Is omega-3 a replacement for statins?
No. Omega-3s lower triglycerides, while statins lower LDL cholesterol. These are different mechanisms, and they do not replace each other. Do not stop medications without a doctor.
Who are omega-3s definitely indicated for the heart?
People with elevated triglycerides, high cardiovascular risk and those who eat little fatty fish. A doctor selects the dose and form.
Do omega-3s affect blood pressure?
Yes, omega-3s provide a moderate reduction in blood pressure, especially in people with elevated BP. The effect is small but useful in combination.
What to do with high triglycerides?
Reduce sugar and alcohol, add fatty fish and physical activity. With significantly high levels, a doctor may prescribe high doses of EPA or other drugs.
Should I take omega-3 if I am healthy?
For general health — yes, they are beneficial fats for the brain, eyes and heart. But do not expect guaranteed protection from heart attacks if your indicators are normal and there is no high risk.
How to choose omega-3 for the heart?
Look at the milligrams of EPA+DHA (EPA matters), the form (TG/rTG absorb better) and purity (IFOS). With high triglycerides — high doses of EPA as prescribed by a doctor.